Watch VideoAn experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on the medication from drugmaker Merck.
The Food and Drug Administration is asking its outside experts whether the agency...
FDA Reviewing Merck's COVID Pill For Emergency Authorization
Newsy
0 shares
2 views
You might like
Related news coverage
Womp, womp: Efficacy of Merck’s Thor-inspired COVID pill crumbles, vexing experts
Ars Technica
FDA advisors voted 13-to-10 in favor of authorization given risks and modest benefits.
-
Alert: FDA health panel endorses Merck COVID-19 pill, paving way for U.S. authorization of the first at-home drug for virus
SeattlePI.com
-
FDA advisors recommend authorization of Merck COVID antiviral pill molnupiravir
SeekingAlpha
-
FDA panel narrowly backs COVID-19 pill from Merck
Newsday
-
Final US hurdle for Merck's COVID-19 pill: FDA panel review
SeattlePI.com
Advertisement
More coverage
FDA Says Merck COVID Pill Effective, Experts To Review Safety
Newsy
Watch VideoFederal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will..
-
Merck asks EU regulator to authorize its COVID-19 pill
SeattlePI.com
-
Pfizer, US ink $5.29B deal for possible COVID-19 treatment
SeattlePI.com
-
Pfizer asks US officials to OK promising COVID-19 pill
SeattlePI.com
-
Pfizer Seeks Emergency Use Authorization From FDA For Investigational Covid-19 Treatment Pill
RTTNews